Literature DB >> 34515155

Diagnostic Dilemma in an Adolescent Girl with an Eating Disorder, Intellectual Disability, and Hypomagnesemia.

Abdulaziz A Bamhraz1, Gijs A C Franken2, Jeroen H F de Baaij2, Allison Rodrigues3, Rosheen Grady3, Stephanie Deveau3, Rahul Chanchlani4.   

Abstract

Neurological disorders, including seizures, migraine, depression, and intellectual disability, are frequently associated with hypomagnesemia. Specifically, magnesium (Mg2+) channel transient receptor potential melastatin (TRPM) 6 and TRPM7 are essential for brain function and development. Both channels are also localized in renal and intestinal epithelia and are crucial for Mg2+(re)absorption. Cyclin M2 (CNNM2) is located on the basolateral side of the distal convoluted tubule. In addition, it plays a role in the maintenance of plasma Mg2+ levels along with TRPM6, which is present at the apical level. The CNNM2 gene is crucial for renal magnesium handling, brain development, and neurological functioning. Here, we identified a novel mutation in the CNNM2 gene causing a cognitive delay in a girl with hypomagnesemia. We suggest testing for CNNM2 mutation in patients with neurological impairment and hypomagnesemia.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Eating disorder; Hypomagnesemia; Intellectual disability

Mesh:

Substances:

Year:  2021        PMID: 34515155     DOI: 10.1159/000518173

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Novel CNNM2 Mutation Responsible for Autosomal-Dominant Hypomagnesemia With Seizure.

Authors:  Min-Hua Tseng; Sung-Sen Yang; Chih-Chien Sung; Jhao-Jhuang Ding; Yu-Juei Hsu; Shih-Ming Chu; Shih-Hua Lin
Journal:  Front Genet       Date:  2022-06-29       Impact factor: 4.772

2.  Rare hypomagnesemia, seizures, and mental retardation in a 4-month-old patient caused by novel CNNM2 mutation Tyr189Cys: Genetic analysis and review.

Authors:  Xiaoyan Xu; Shu Hou; Weiwei Sun; Jing Zhu; Jinjing Yuan; Zhenzhen Cui; Jiulai Tang
Journal:  Mol Genet Genomic Med       Date:  2022-02-16       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.